The Oncology Drugs Global Market Report 2020-30 by The Business Research Company describes and explains the global oncology drugs market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.
The Oncology Drugs Global Market Opportunities And Strategies Report covers oncology drugs market drivers, oncology drugs market trends, oncology drugs market segments, oncology drugs market growth rate, oncology drugs market major players, and oncology drugs market size.
View Complete Report: https://www.thebusinessresearchcompany.com/report/oncology-drugs-market
The oncology drugs market report focuses particularly on identifying the trends, opportunities, and strategies that can lead to success. O&S reports are available off the shelf and can be delivered to clients on the day of purchase.
Oncology Drugs Global Market Opportunities And Strategies Report is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
Request For The Sample Now: https://www.thebusinessresearchcompany.com/sample.aspx?id=3440&type=smp
Trends in the market include:
Development Of Personalized Cancer Vaccines-
Drug manufacturers are investing in developing personalized cancer vaccines, and few have reached clinical trial phases. Pharmaceutical companies are combining genetic sequencing and precision medicine to create new drug therapies and cancer treatments that are designed to treat specific patients. For instance, in 2016, Merck, an American pharmaceutical company collaborated with Moderna Therapeutics, an American biotech company pioneer of messenger RNA Therapeutics to develop and commercialize novel messenger RNA (mRNA)-based personalized cancer vaccines. In 2019, Moderna announced the result from the ongoing Phase 1 clinical study in patients with both resected (adjuvant) and unresected (advanced) solid tumors. The results were positive when mRNA mRNA personalized cancer vaccine (PCV) mRNA-4157, given alone or in combination with Merck’s pembrolizumab (KEYTRUDA®). Currently the vaccine is in phase 2 clinical trial.
Use Of 3D Printing To Test New Oncology Drugs-
Manufacturers of oncology drugs are investing in 3D printing devices that mimic the human body to test new oncology drugs, hence reducing the time taken for approval and reducing clinical patient trials. These 3D printed devices are cheap to produce and can be fabricated quickly and easily, thus saving time and cutting costs. This method also allows personalization of medicine, as an individual patient’s tumor may be replicated to create the device, and different treatment methods may be tested on the device until the most effective treatment option is found. For example, Knight Cancer Institute is relying on San Diego based company, Organovo that designs three dimensional human tissues for medical research applications, for discovering and testing new cancer drugs.
The market is segmented:
By Type -
1. Blood Cancer
2. Breast Cancer
3. Lung Cancer
4. Prostate Cancer
5. Colorectal Cancer
6. Cervical Cancer
7. Kidney Cancer
8. Gastric Cancer
9. Brain Tumor
10. Skin Cancer
11. Ovarian Cancer
12. Bladder Cancer
13. Pancreatic Cancer
14. Thyroid Cancer
15. Others
By Drug Class Type –
1. Targeted Therapy
2. Immunotherapy (Biologic Therapy)
3. Chemotherapy
4. Hormonal Therapy
By Distribution Channel –
1. Retail Pharmacies/Drug Stores
2. Hospital Pharmacies
3. Others
By Route Of Administration –
1. Oral
2. Parenteral
3. Others
By Drug Classification –
1. Branded
2. Generic
About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
